From treating depression and other mental health disorders, to helping relieve chronic pain, researchers discuss the advantages and implications of psychedelic treatments.
Pain
Pain Neuroscience news articles cover science research about pain receptors, nociceptors, nociception, sensory neurons, somatosensory cortex, chronic pain, acute pain, nocioceptors, musculoskeletal pain, therapies, phantom limb pain and other pain research.
Reducing sensitivity to physical pain resulted in a reduction of pain empathy toward others, a study found. The results suggest a possible neurobiological link between pain and empathy.
Teens who have self-harmed five or more times in their lives have a significantly higher pain threshold than those who have never self-harmed.
Cannabis terpenes, the part of the plant which provides aroma and flavor, may provide therapeutic benefits in controlling pain, a new study reports.
Researchers investigate whether vaporized THC, the psychoactive compound in cannabis, alters behaviors and pain responses in lobsters bound for the boiling pot.
Synthetically optimizing a peptide commonly found in sunflower seeds could help provide relief for gastrointestinal pain and inflammation, a new study reports.
A Western-style diet, high in omega-6 polyunsaturated fats, increases symptoms of inflammation, neuropathy, and chronic pain. However, changing to a lower-fat diet can help reverse or relieve symptoms of inflammatory pain disorders.
Smartphone-based virtual reality games helped to reduce pain in young children with burns while having their dressing changed, a new study reports.
Conolidine, a natural pain killer derived from the pinwheel flower and frequently used in Chinese medicine, interacts with a newly identified opioid receptor that regulates natural opioid peptides produced in the brain.
NapA, a protein associated with the peptidoglycan of Borrelia burgdorferi, plays an amplifying role in causing inflammation in Lyme disease associated arthritis.
A new study reports the number of people reporting chronic pain is rising across every age group and demographic.
KLS-13019, a novel CBD analog, shows promise at reversing pain sensitivity and preventing symptoms of neuropathy in mouse models of chemotherapy-induced peripheral neuropathy.
